Yes.
Gets publicity.
Isn't Nature a 'pay for article' publication though?
https://www.nature.com/nature/for-authors/publishing-options
https://english.elpais.com/science-tech/2023-11-21/scientists-paid-large-publishers-over-1-billion-in-four-years-to-have-their-studies-published-with-open-access.html
Cost share holders $12,000 for that.
I'm not sure you can claim 85% without stating "85% with NO vascular or diabetic improvement in the trial period".
That's just me though.
Regardless, thanks for the polite reply.
Cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58708 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 9763 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |